...
optn-img

OptiNose, Common Stock

OPTN

NSQ

$0.486

-$0.01

(-2.02%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$74.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
229.80K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.07
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.32 L
$2.1 H
$0.486

About OptiNose, Common Stock

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameOPTNSectorS&P500
1-Week Return-2.34%-2.82%0.15%
1-Month Return-18.62%-4.22%1.78%
3-Month Return-47.78%-9.52%8.7%
6-Month Return-60.62%-3.45%12.24%
1-Year Return-58.26%5.62%30.9%
3-Year Return-69.48%3.8%30.19%
5-Year Return-94.83%39.68%91.72%
10-Year Return-97.43%105.02%203.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue34.63M49.12M74.65M76.28M70.99M[{"date":"2019-12-31","value":45.4,"profit":true},{"date":"2020-12-31","value":64.39,"profit":true},{"date":"2021-12-31","value":97.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.07,"profit":true}]
Cost of Revenue5.29M7.52M9.15M9.26M8.63M[{"date":"2019-12-31","value":57.15,"profit":true},{"date":"2020-12-31","value":81.18,"profit":true},{"date":"2021-12-31","value":98.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.2,"profit":true}]
Gross Profit29.34M41.60M65.50M67.01M62.35M[{"date":"2019-12-31","value":43.78,"profit":true},{"date":"2020-12-31","value":62.07,"profit":true},{"date":"2021-12-31","value":97.74,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.05,"profit":true}]
Gross Margin84.71%84.69%87.74%87.86%87.84%[{"date":"2019-12-31","value":96.42,"profit":true},{"date":"2020-12-31","value":96.4,"profit":true},{"date":"2021-12-31","value":99.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.98,"profit":true}]
Operating Expenses124.94M128.82M131.95M122.91M85.10M[{"date":"2019-12-31","value":94.69,"profit":true},{"date":"2020-12-31","value":97.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.15,"profit":true},{"date":"2023-12-31","value":64.5,"profit":true}]
Operating Income(95.60M)(87.22M)(66.45M)(55.90M)(22.75M)[{"date":"2019-12-31","value":-9560100000,"profit":false},{"date":"2020-12-31","value":-8721900000,"profit":false},{"date":"2021-12-31","value":-6645000000,"profit":false},{"date":"2022-12-31","value":-5589600000,"profit":false},{"date":"2023-12-31","value":-2274800000,"profit":false}]
Total Non-Operating Income/Expense(21.72M)(25.15M)(31.77M)(35.27M)(29.74M)[{"date":"2019-12-31","value":-2171600000,"profit":false},{"date":"2020-12-31","value":-2514900000,"profit":false},{"date":"2021-12-31","value":-3176700000,"profit":false},{"date":"2022-12-31","value":-3526700000,"profit":false},{"date":"2023-12-31","value":-2973600000,"profit":false}]
Pre-Tax Income(110.05M)(99.79M)(82.30M)(74.83M)(35.48M)[{"date":"2019-12-31","value":-11005300000,"profit":false},{"date":"2020-12-31","value":-9978600000,"profit":false},{"date":"2021-12-31","value":-8229600000,"profit":false},{"date":"2022-12-31","value":-7483300000,"profit":false},{"date":"2023-12-31","value":-3548300000,"profit":false}]
Income Taxes(1.11M)(1.46M)(646.00K)1.56M234.10K[{"date":"2019-12-31","value":-70.93,"profit":false},{"date":"2020-12-31","value":-93.21,"profit":false},{"date":"2021-12-31","value":-41.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.99,"profit":true}]
Income After Taxes(108.94M)(98.33M)(81.65M)(76.39M)(35.72M)[{"date":"2019-12-31","value":-10894500000,"profit":false},{"date":"2020-12-31","value":-9833000000,"profit":false},{"date":"2021-12-31","value":-8165000000,"profit":false},{"date":"2022-12-31","value":-7639500000,"profit":false},{"date":"2023-12-31","value":-3571710500,"profit":false}]
Income From Continuous Operations(110.05M)(99.78M)(82.37M)(72.23M)(35.48M)[{"date":"2019-12-31","value":-11005300000,"profit":false},{"date":"2020-12-31","value":-9978500000,"profit":false},{"date":"2021-12-31","value":-8237100000,"profit":false},{"date":"2022-12-31","value":-7222600000,"profit":false},{"date":"2023-12-31","value":-3548300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(108.94M)(98.33M)(81.65M)(76.39M)(35.48M)[{"date":"2019-12-31","value":-10894500000,"profit":false},{"date":"2020-12-31","value":-9833000000,"profit":false},{"date":"2021-12-31","value":-8165000000,"profit":false},{"date":"2022-12-31","value":-7639500000,"profit":false},{"date":"2023-12-31","value":-3548300000,"profit":false}]
EPS (Diluted)(2.63)(2.08)(1.48)(0.89)(0.32)[{"date":"2019-12-31","value":-263,"profit":false},{"date":"2020-12-31","value":-208,"profit":false},{"date":"2021-12-31","value":-148,"profit":false},{"date":"2022-12-31","value":-89,"profit":false},{"date":"2023-12-31","value":-32,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OPTN
Cash Ratio 0.51
Current Ratio 0.79
Quick Ratio 0.72

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OPTN
ROA (LTM) -10.32%
ROE (LTM) -1050.50%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OPTN
Debt Ratio Lower is generally better. Negative is bad. 1.31
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.31

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OPTN
Trailing PE NM
Forward PE NM
P/S (TTM) 0.99
P/B 24.26
Price/FCF NM
EV/R 1.60
EV/Ebitda NM

FAQs

What is OptiNose share price today?

OptiNose (OPTN) share price today is $0.486

Can Indians buy OptiNose shares?

Yes, Indians can buy shares of OptiNose (OPTN) on Vested. To buy OptiNose from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OPTN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of OptiNose be purchased?

Yes, you can purchase fractional shares of OptiNose (OPTN) via the Vested app. You can start investing in OptiNose (OPTN) with a minimum investment of $1.

How to invest in OptiNose shares from India?

You can invest in shares of OptiNose (OPTN) via Vested in three simple steps:

  • Click on Sign Up or Invest in OPTN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in OptiNose shares
What is OptiNose 52-week high and low stock price?

The 52-week high price of OptiNose (OPTN) is $2.1. The 52-week low price of OptiNose (OPTN) is $0.32.

What is OptiNose price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of OptiNose (OPTN) is

What is OptiNose price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of OptiNose (OPTN) is 24.26

What is OptiNose dividend yield?

The dividend yield of OptiNose (OPTN) is 0.00%

What is the Market Cap of OptiNose?

The market capitalization of OptiNose (OPTN) is $74.66M

What is OptiNose’s stock symbol?

The stock symbol (or ticker) of OptiNose is OPTN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top